Alkermes plc. — Director's Dealing 2019

Feb 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2019-02-21

Reporting Person: Hopkinson Craig C. (SVP, Med Dev/Med Affairs, CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-21	Employee Stock Option (Right to Buy)	$32.57	A	106700	Acquired	2029-02-21	Ordinary Shares (106700)	Direct
2019-02-21	Restricted Stock Unit Award	$0	A	27500	Acquired		Ordinary Shares (27500)	Direct

Footnotes

F1: Shares subject to the stock option award vest in four equal annual installments commencing on 2/21/2020.

F2: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020.